These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9334913)

  • 1. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus.
    Schnell O; Muhr D; Weiss M; Kirsch CM; Haslbeck M; Tatsch K; Standl E
    J Diabetes Complications; 1997; 11(5):307-13. PubMed ID: 9334913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic control.
    Muhr-Becker D; Weiss M; Tatsch K; Wolfram G; Standl E; Schnell O
    Exp Clin Endocrinol Diabetes; 1999; 107(5):306-12. PubMed ID: 10482043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up.
    Schnell O; Muhr D; Dresel S; Weiss M; Haslbeck M; Standl E
    Diabet Med; 1997 Jan; 14(1):57-62. PubMed ID: 9017355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.
    Schnell O; Kirsch CM; Stemplinger J; Haslbeck M; Standl E
    Diabetologia; 1995 Nov; 38(11):1345-52. PubMed ID: 8582545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
    Schnell O; Muhr D; Weiss M; Dresel S; Haslbeck M; Standl E
    Diabetes; 1996 Jun; 45(6):801-5. PubMed ID: 8635656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy.
    Schnell O; Hammer K; Muhr-Becker D; Ziegler A; Weiss M; Tatsch K; Standl E
    J Diabetes Complications; 2002; 16(3):220-7. PubMed ID: 12015192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
    Langer A; Freeman MR; Josse RG; Armstrong PW
    J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
    Turpeinen AK; Vanninen E; Kuikka JT; Uusitupa MI
    Diabetes Care; 1996 Oct; 19(10):1083-90. PubMed ID: 8886553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients.
    Ziegler D; Weise F; Langen KJ; Piolot R; Boy C; Hübinger A; Müller-Gärtner HW; Gries FA
    Diabetologia; 1998 Apr; 41(4):443-51. PubMed ID: 9562349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus.
    Meier M; Muhr D; Weiss M; Tatsch K; Standl E; Schnell O
    J Diabetes Complications; 2000; 14(2):90-5. PubMed ID: 10959071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy.
    Miranda CH; Figueiredo AB; Maciel BC; Marin-Neto JA; Simões MV
    J Nucl Med; 2011 Apr; 52(4):504-10. PubMed ID: 21441532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients.
    Schsnell O; Muhr D; Dresel S; Tatsch K; Ziegler AG; Haslbeck M; Standl E
    Diabetologia; 1996 Aug; 39(8):970-5. PubMed ID: 8858220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic reinnervation after acute myocardial infarction.
    Hartikainen J; Kuikka J; Mäntysaari M; Länsimies E; Pyörälä K
    Am J Cardiol; 1996 Jan; 77(1):5-9. PubMed ID: 8540457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities.
    Parthenakis FI; Prassopoulos VK; Koukouraki SI; Zacharis EA; Diakakis GF; Karkavitsas NK; Vardas PE
    J Nucl Cardiol; 2002; 9(1):15-22. PubMed ID: 11845125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
    Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
    Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function.
    Kreiner G; Wolzt M; Fasching P; Leitha T; Edlmayer A; Korn A; Waldhäusl W; Dudczak R
    Diabetes; 1995 May; 44(5):543-9. PubMed ID: 7729613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.
    Simula S; Vanninen E; Viitanen L; Kareinen A; Lehto S; Pajunen P; Syvänne M; Kuikka J; Laakso M; Hartikainen J
    J Nucl Med; 2002 Jan; 43(1):1-7. PubMed ID: 11801695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease.
    Koistinen MJ; Airaksinen KE; Huikuri HV; Linnaluoto MM; Heikkila J; Torniainen P; Ahonen A
    Diabetes Care; 1996 Mar; 19(3):231-3. PubMed ID: 8742567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.